Cosibelimab (Anti-B7-H1 / PD-L1 / CD274)
Product Specifications
CAS Number
2216751-26-5
Synonyms
CK-301; TG-1501
Target
PD-1/PD-L1
Applications
Apoptosis
Additionnal Information
Cosibelimab (Anti-B7-H1 / PD-L1 / CD274) is an immunoglobulin G1 (IgG1), human monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1; cluster of differentiation 274; CD274), with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.64 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog